3D MR brings new insight into bipolar disorders

Article

Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.

Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.

Principal investigator Carrie Bearden, Ph.D., and colleagues at the University of California, Los Angeles enrolled 28 adult patients with bipolar disorder, most of whom were being treated with lithium, and 28 healthy subjects. The investigators used 3D structural brain mapping to analyze gray matter spots at multiple cortical locations. They found a statistically significant difference in gray matter density between bipolar patients and control subjects in the brain regions that control attention, motivation, and emotion. The technique will help develop new treatments that match lithium's effectiveness but without its toxic effects, Bearden said.

Investigators published results in the July issue of Biological Psychiatry.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.